CASTRATION RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heartburn drug could boost Last-Line prostate cancer treatment
Disease control Recruiting nowThis study is testing if adding a common heartburn medication (omeprazole) to a standard chemotherapy drug (cabazitaxel) can better control advanced prostate cancer that has stopped responding to other treatments. It will involve about 50 men whose cancer has progressed despite p…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Apr 01, 2026 19:56 UTC
-
New weapon against advanced cancer enters human testing
Disease control Recruiting nowThis is the first study in people testing a new cancer drug called MGC026. It aims to find a safe dose and see if the drug can help shrink tumors in adults with advanced solid tumors that have not responded to other treatments. The study will also check how the drug moves through…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for men with Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing a new drug called ifinatamab deruxtecan, both by itself and combined with other treatments, for men with advanced prostate cancer that has spread and no longer responds to standard hormone therapy. The main goals are to find a safe dose, see how well the bod…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for men battling aggressive prostate cancer
Disease control Recruiting nowThis is the first study in people to test a new drug called JANX007 for men with advanced prostate cancer that has spread and no longer responds to standard hormone-blocking treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will…
Matched conditions: CASTRATION RESISTANT PROSTATIC CANCER
Phase: PHASE1 • Sponsor: Janux Therapeutics • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC